What is Dyne Therapeutics, Inc.'s stock issuance proceeds?

Dyne Therapeutics, Inc. (DYN) reported stock issuance proceeds of $0 in Q1 2026.

How has Dyne Therapeutics, Inc.'s stock issuance proceeds changed year-over-year?

Dyne Therapeutics, Inc.'s stock issuance proceeds decreased by 100.0% year-over-year, from $140.65M to $0.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Dyne Therapeutics, Inc. DYN Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Ionis PharmaceuticalsIONS

$57.3M+2,457%

Arrowhead ResearchARWR

$46.83M—

Edgewise Therapeutics, Inc.EWTX

$12.17M+438%

PTC TherapeuticsPTCT

$6.4M-59.3%

Scholar RockSRRK

$98M+1,852%

Catalyst PharmaceuticalCPRX

$3.3M—

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s stock issuance proceeds?: Dyne Therapeutics, Inc. (DYN) reported stock issuance proceeds of $0 in Q1 2026.
How has Dyne Therapeutics, Inc.'s stock issuance proceeds changed year-over-year?: Dyne Therapeutics, Inc.'s stock issuance proceeds decreased by 100.0% year-over-year, from $140.65M to $0.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.